What's New in Pediatric Spine Growth Modulation and Implant Technology for Early-Onset Scoliosis?

Nolan M. Wessell, Jeffrey E. Martus, Matthew A. Halanski, Brian Snyder, Walter Truong

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Early-onset scoliosis (EOS) affects roughly 1 to 2 out of 10,000 live births per year. Because this subset of patients has a yet to achieve a majority of their skeletal growth, a number of treatment challenges need to be addressed before surgical intervention. If left untreated, EOS can cause a number of problems throughout the patient's lifespan, particularly in regards to the growth of the thorax and pulmonary development. A wide variety of surgical systems and techniques are available to the treating surgeon. A review of the orthopaedic literature from 2010 to 2015 relating to pediatric spine growth modulation was performed. Ninety-eight papers were identified and, following exclusion criteria, a total of 31 papers were selected for further review. This paper summarizes the recently published literature regarding growth-friendly spinal implants, the status of their Food and Drug Administration approval labeling as well as the indications, applications, and complications associated with their implementation. There are a growing number of options at the surgeon's disposal when treating patients with EOS. As surgeons, we must continue to be vigilant in our demand for sound clinical evidence as we strive to provide optimal care for our patients. The rapidly advancing field of spinal growth modulation is exciting. More work must be done to further enhance our ability to predictably modulate growth in the pediatric spine.

Original languageEnglish (US)
Pages (from-to)e3-e13
JournalJournal of Pediatric Orthopaedics
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Scoliosis
Spine
Pediatrics
Technology
Growth
Drug Approval
Live Birth
United States Food and Drug Administration
Orthopedics
Patient Care
Thorax
Lung
Surgeons

Keywords

  • early-onset scoliosis
  • growth modulation
  • implant technology
  • spine growth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Orthopedics and Sports Medicine

Cite this

What's New in Pediatric Spine Growth Modulation and Implant Technology for Early-Onset Scoliosis? / Wessell, Nolan M.; Martus, Jeffrey E.; Halanski, Matthew A.; Snyder, Brian; Truong, Walter.

In: Journal of Pediatric Orthopaedics, Vol. 38, No. 1, 01.01.2018, p. e3-e13.

Research output: Contribution to journalReview article

Wessell, Nolan M. ; Martus, Jeffrey E. ; Halanski, Matthew A. ; Snyder, Brian ; Truong, Walter. / What's New in Pediatric Spine Growth Modulation and Implant Technology for Early-Onset Scoliosis?. In: Journal of Pediatric Orthopaedics. 2018 ; Vol. 38, No. 1. pp. e3-e13.
@article{af6f989018184d68a5c093193fdd07ef,
title = "What's New in Pediatric Spine Growth Modulation and Implant Technology for Early-Onset Scoliosis?",
abstract = "Early-onset scoliosis (EOS) affects roughly 1 to 2 out of 10,000 live births per year. Because this subset of patients has a yet to achieve a majority of their skeletal growth, a number of treatment challenges need to be addressed before surgical intervention. If left untreated, EOS can cause a number of problems throughout the patient's lifespan, particularly in regards to the growth of the thorax and pulmonary development. A wide variety of surgical systems and techniques are available to the treating surgeon. A review of the orthopaedic literature from 2010 to 2015 relating to pediatric spine growth modulation was performed. Ninety-eight papers were identified and, following exclusion criteria, a total of 31 papers were selected for further review. This paper summarizes the recently published literature regarding growth-friendly spinal implants, the status of their Food and Drug Administration approval labeling as well as the indications, applications, and complications associated with their implementation. There are a growing number of options at the surgeon's disposal when treating patients with EOS. As surgeons, we must continue to be vigilant in our demand for sound clinical evidence as we strive to provide optimal care for our patients. The rapidly advancing field of spinal growth modulation is exciting. More work must be done to further enhance our ability to predictably modulate growth in the pediatric spine.",
keywords = "early-onset scoliosis, growth modulation, implant technology, spine growth",
author = "Wessell, {Nolan M.} and Martus, {Jeffrey E.} and Halanski, {Matthew A.} and Brian Snyder and Walter Truong",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/BPO.0000000000000830",
language = "English (US)",
volume = "38",
pages = "e3--e13",
journal = "Journal of Pediatric Orthopaedics",
issn = "0271-6798",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - What's New in Pediatric Spine Growth Modulation and Implant Technology for Early-Onset Scoliosis?

AU - Wessell, Nolan M.

AU - Martus, Jeffrey E.

AU - Halanski, Matthew A.

AU - Snyder, Brian

AU - Truong, Walter

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Early-onset scoliosis (EOS) affects roughly 1 to 2 out of 10,000 live births per year. Because this subset of patients has a yet to achieve a majority of their skeletal growth, a number of treatment challenges need to be addressed before surgical intervention. If left untreated, EOS can cause a number of problems throughout the patient's lifespan, particularly in regards to the growth of the thorax and pulmonary development. A wide variety of surgical systems and techniques are available to the treating surgeon. A review of the orthopaedic literature from 2010 to 2015 relating to pediatric spine growth modulation was performed. Ninety-eight papers were identified and, following exclusion criteria, a total of 31 papers were selected for further review. This paper summarizes the recently published literature regarding growth-friendly spinal implants, the status of their Food and Drug Administration approval labeling as well as the indications, applications, and complications associated with their implementation. There are a growing number of options at the surgeon's disposal when treating patients with EOS. As surgeons, we must continue to be vigilant in our demand for sound clinical evidence as we strive to provide optimal care for our patients. The rapidly advancing field of spinal growth modulation is exciting. More work must be done to further enhance our ability to predictably modulate growth in the pediatric spine.

AB - Early-onset scoliosis (EOS) affects roughly 1 to 2 out of 10,000 live births per year. Because this subset of patients has a yet to achieve a majority of their skeletal growth, a number of treatment challenges need to be addressed before surgical intervention. If left untreated, EOS can cause a number of problems throughout the patient's lifespan, particularly in regards to the growth of the thorax and pulmonary development. A wide variety of surgical systems and techniques are available to the treating surgeon. A review of the orthopaedic literature from 2010 to 2015 relating to pediatric spine growth modulation was performed. Ninety-eight papers were identified and, following exclusion criteria, a total of 31 papers were selected for further review. This paper summarizes the recently published literature regarding growth-friendly spinal implants, the status of their Food and Drug Administration approval labeling as well as the indications, applications, and complications associated with their implementation. There are a growing number of options at the surgeon's disposal when treating patients with EOS. As surgeons, we must continue to be vigilant in our demand for sound clinical evidence as we strive to provide optimal care for our patients. The rapidly advancing field of spinal growth modulation is exciting. More work must be done to further enhance our ability to predictably modulate growth in the pediatric spine.

KW - early-onset scoliosis

KW - growth modulation

KW - implant technology

KW - spine growth

UR - http://www.scopus.com/inward/record.url?scp=84978152952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978152952&partnerID=8YFLogxK

U2 - 10.1097/BPO.0000000000000830

DO - 10.1097/BPO.0000000000000830

M3 - Review article

C2 - 27403917

AN - SCOPUS:84978152952

VL - 38

SP - e3-e13

JO - Journal of Pediatric Orthopaedics

JF - Journal of Pediatric Orthopaedics

SN - 0271-6798

IS - 1

ER -